NIH's new rare disease push
The National Institutes of Health has thrown its hat into the drug development ring with the announcement of a new program that will seek to bring drugs that treat rare and neglected diseases onto the market. "This is a tremendously important initiative for people with rare diseases," Peter Saltonstall, president of the linkurl:National Organization for Rare Disorders;http://www.rarediseases.org/ (NORD), said in a linkurl:statement.;http://www.rarediseases.org/news/TRND "There are nearly 7,000
Written byBob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
View Full Profile
Learn about our Editorial Policies.
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
**__Related stories:__***linkurl:The positives of globalization;http://www.the-scientist.com/news/display/55479/
[25th February 2009]*linkurl:Twin Disorders;http://www.the-scientist.com/article/display/55136/
[November 2008]*linkurl:The Orphan Drug Act Turns 25;http://www.the-scientist.com/article/display/55041/
[October 2008]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
Share
